House Would Slow US FDA Budget Authority Increases In FY 2021
After two years of significant growth in non-user fee funds, House appropriators offer FDA a more modest increase for FY 2021.
You may also be interested in...
Will Califf’s Attention To Foods Come At Expense Of US FDA’s Drugs Program?
FDA Commissioner Robert Califf says the medical product programs have received a lot of attention and now it’s the food program’s turn.
US FDA's Biologics Center May Get Its Day In PDUFA VII
Multiple stakeholders call for CBER to receive more prescription drug user fee funds amid growing cell and gene therapy popularity.
US FDA Would Get Mandatory Recall Authority For Drugs Under House Funding Bill
The change would let FDA forcibly pull prescription and over-the-counter drugs off the market just like vaccines, medical devices and other products.